匹布伦他韦

Name: 匹布伦他韦
Brand: 济南圣和化工有限公司

CAS 1353900-92-1C57H65F5N10O8MW 1113.2

匹布伦他韦，CAS 登记号 1353900-92-1，由济南圣和化工有限公司现货供应，可提供纯度按批次COA提供(不公开发布) 的规格，下游主要用于有机化学品。支持样品与小批量试用，批量价格请联系我们获取，验收以批次 COA 为准。

规格参数

CAS号1353900-92-1

分子式C57H65F5N10O8

分子量1113.2

LogP7.4

纯度按批次COA提供(不公开发布)

包装按订单/批次确认(不公开发布)

应用领域有机化学品

类别有机化学品

用途与场景

有机化学品

包装与供货

包装规格按订单/批次确认(不公开发布)

纯度规格按批次COA提供(不公开发布)

储存条件密封、阴凉干燥处保存

供货周期现货/按订单安排

文件与支持

每批随货提供 COA；可按需提供 MSDS 及技术文件。邮件注明产品名称与 CAS 号，一个工作日内回复报价。

常见问题

在哪里能查到匹布伦他韦的 CAS 号？

本页已列出匹布伦他韦的 CAS 号：1353900-92-1，可与随货 COA 核对。

可以提供哪些规格和包装？

常见纯度为按批次COA提供(不公开发布)，包装形式为按订单/批次确认(不公开发布)，特殊规格可在询价时说明。

匹布伦他韦一般用在什么产品里？

主要涉及有机化学品。

下单流程是怎样的？

来信 info@591daili.com 或 WhatsApp 联系，提供产品名称、CAS 号与数量，确认价格与交期后即可安排发货，验收以批次 COA 为准。

PubChem 公开数据

Description

Pibrentasvir · CAS 1353900-92-1 · C57H65F5N10O8. UNII 2WU922TK3L. Solubility: <0.1 mg/mL.

Identification

CAS Registry Number	1353900-92-1
PubChem CID	58031952
Molecular formula	C57H65F5N10O8
UNII (FDA)	2WU922TK3L

Computed Descriptors

Molecular Weight	1113.2
XLogP3	7.4
Hydrogen Bond Donor Count	4
Hydrogen Bond Acceptor Count	17
Rotatable Bond Count	17
Exact Mass	1112.49069988
Monoisotopic Mass	1112.49069988
Topological Polar Surface Area	200
Heavy Atom Count	80
Formal Charge	0

Physical & Chemical Properties

Solubility	<0.1 mg/mL

GHS Hazard Classification

Reported hazard statements	H315 (100%), H319 (100%), H335 (100%), H413 (100%)

H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]

H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]

Documented Uses

Indicated for the treatment of adult patients with acute and chronic hepatitis C virus (HCV) genotype 1, 2, 3, 4, 5 or 6 infection without cirrhosis or with compensated cirrhosis (Child-Pugh A). MAVYRET is also indicated for the treatment of adult patients with HCV genotype 1 infection, who previously have been treated with a regimen containing an HCV NS5A inhibitor or an NS3/4A protease inhibitor (PI), but not both.
Breast Feeding; Lactation; Milk, Human; Antiviral Agents; NS5A Inhibitors
Avoid St. John's Wort. Co-administration may lead to decreased serum concentrations of pibrentasvir.
Established Pharmacologic Class [EPC] - Hepatitis C Virus NS5A Inhibitor
Mechanisms of Action [MoA] - P-Glycoprotein Inhibitors
Mechanisms of Action [MoA] - Breast Cancer Resistance Protein Inhibitors

Synonyms

Pibrentasvir; 1353900-92-1; ABT-530; A-1325912.0; 2WU922TK3L; DTXSID601027946; pibrentasvirum; RefChem:863096; DTXCID501513514; 829-351-5; Pibrentasvir [USAN]; ABT 530; Abt530; D10816; Pibrentasvir (ABT-530); C57H65F5N10O8

Frequently Asked Questions

What are the CAS number and molecular formula of Pibrentasvir?

CAS 1353900-92-1; molecular formula C57H65F5N10O8; molecular weight — g/mol.

What other names is Pibrentasvir known by?

Pibrentasvir, 1353900-92-1, ABT-530, A-1325912.0, 2WU922TK3L, DTXSID601027946.

Is Pibrentasvir classified as hazardous?

Hazard statements reported: H315, H319, H335, H413.

What are the key physical properties of Pibrentasvir?

Solubility: <0.1 mg/mL.

Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.

获取匹布伦他韦报价

供应商：济南圣和化工有限公司 · 一个工作日内回复。

邮件询价 WhatsApp